Worldwide distribution of prekallikrein (PK) deficiency: the defect seems mainly concentrated in West African countries and in the United States Worldwide distribution of PK deficiency:

Main Article Content

Antonio Girolami
Silvia Ferrari



Download data is not yet available.
Abstract 170 | PDF Downloads 53 HTML Downloads 24


1. Hathaway WE, Belhasen LP, Hathaway HS. Evidence for a new plasma thromboplastin factor. I. Case report, coagulation studies and physicochemical properties. Blood. 1965;26:521-532. PMid:5845778
2. Hathaway WE, Wuepper KD, Weston WL, Humbert JR, Rivers RP, Genton E, August CS, Montgomery RR, Mass MF. Clinical and physiologic studies of two siblings with prekallikrein (Fletcher factor) deficiency. Am J Med. 1976;60:654-664.
3. Girolami A, Scarparo P, Candeo N, Lombardi AM. Congenital prekallikrein deficiency. Expert Rev Hematol. 2010;3:685-595. PMid:21091145
4. Sollo DG, Saleem A. Prekallikrein (Fletcher factor) deficiency. Ann Clin Lab Sci. 1985;15:279-285.5. Girolami A, Ferrari S, Cosi E, Girolami B. The high prevalence of Prekallikrein deficiency among African Americans deserves further
studies. Hematol Med Oncol. 2020;5:1-2.
6. Girolami A, Ferrari S, Cosi E, Girolami B. Increased Prevalence of Reported Cases of Congenital Prekallikrein Deficiency Among African Americans as Compared With the General Population of the United
States. Clin Appl Thromb Hemost. 2020;26:1-3. PMid:32243188 PMCid:PMC7288793
7. Essien EM, Ebhota MI. Fletcher Factor Deficiency - Detection of a Severe Case in a Population Survey. Acta Haematol. 1977;58:353-358. PMid:413313
8. Adenaeuer A, Ezigbo ED, Nazir HF, Barco S, Trinchero A, Laubert?Reh D, Strauch K, Wild PS, Lackner KJ, Lämmle B, Rossmann H.c. 451dupT in KLKB1 is common in Nigerians, confirming a higher
prevalence of severe prekallikrein deficiency in Africans compared to Europeans. J Thrombo Hemostas. 2020. PMid:33073460
9. Dasgupta SK, Rivera S, Thiagarajan P. Lisinopril-Induced Angioedema in a Patient with Plasma Prekallikrein Deficiency. TH Open. 2020;4:e33-e35. PMid:31984307 PMCid:PMC6978173
10. Mendy VL, Vargas R, Payton M, Sims JN, Zhang L. Trends in the Stroke Death Rate Among Mississippi Adults, 2000-2016. Prev Chronic Dis. 2019. 14;16:E21. PMid:30767859 PMCid:PMC6395077
11. Colantonio LD, Monda KL, Rosenson RS, Brown TM, Mues KE, Howard G, Safford MM, Yedigarova L, Farkouh ME, Muntner P. Characteristics and Cardiovascular Disease Event Rates among African Americans and Whites Who Meet the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) Trial
Inclusion Criteria. Cardiovasc Drugs Ther. 2019;33:189-199.
PMid:30746585 PMCid:PMC6917479
12. Waldron FA, Benenson I, Jones-Dillon SA, Zinzuwadia SN, Adeboye AM, Eris E, Mbadugha NE, Vicente N, Over A. Prevalence and risk factors for hypertensive crisis in a predominantly African American inner-city community. Blood Press. 2019;28:114-123. PMid:30669866